This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
Stem Cell Research & Therapy Open Access 08 November 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Frewer, L.J. et al. Br. Med. J. 340, c1862 (2010).
European Parliament and the Council. Official J. Eur. Union 27.5.2014, 1–76 http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32014R0536&qid=1454696912906&from=EN (2014).
Hunter, P. EMBO Rep. 12, 110–112 (2011).
Abou-El-Enein, M., Bauer, G., Reinke, P., Renner, M. & Schneider, C.K. Trends Mol. Med. 20, 632–642 (2014).
Glickman, S.W. et al. N. Engl. J. Med. 360, 816–823 (2009).
Mello, M.M. et al. N. Engl. J. Med. 369, 1651–1658 (2013).
EMA. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/10/WC500174767.pdf (2 October 2014).
Schneider, C.K. et al. Nat. Rev. Drug Discov. 9, 195–201 (2010).
Meerpohl, J.J. et al. BMJ Open 5, e006666 (2015).
Corrigan-Curay, J. et al. Mol. Ther. 23, 796–806 (2015).
EMA. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/12/WC500199078.pdf (17 December 2015).
EMA. (http://www.ema.europa.eu/docs/en_GB/document_library/Other/2014/12/WC500179339.pdf (25 March 2015).
Acknowledgements
We gratefully thank colleagues from the EMA, the MHRA and the Danish Health Medicines Agency for their valuable comments on earlier drafts of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Abou-El-Enein, M., Schneider, C. Deciphering the EU clinical trials regulation. Nat Biotechnol 34, 231–233 (2016). https://doi.org/10.1038/nbt.3492
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3492
This article is cited by
-
Diagnosing the declining industry sponsorship in clinical research
Scientometrics (2024)
-
International standards and guidelines for xenotransplantation
Nature Biotechnology (2021)
-
Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
Stem Cell Research & Therapy (2018)